Clinical studies from 2020-2025 consistently report minimal side effects when administered under medical supervision, making them attractive alternatives to traditional anti-inflammatory medications for patients seeking targeted inflammation management
It supports tissue repair, inflammation modulation, and regenerative signaling across muscles, tendons, ligaments, and the gut lining, making it a focus for research in angiogenesis research, injury tissue remodelling, and wellness
References Tesamorelin LiverTox: Clinical and Research Information on Drug-Induced Liver Injury National Institutes of Health, NIDDK (2018) Tesamorelin (Subcutaneous route) Drug Information Mayo Clinic / IBM Merative (2025) Effects of tesamorelin (TH9507), a growth hormonereleasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two phase 3 trials J
Blood pressure BPC-157 affects nitric oxide signaling, which influences vessel tone
Thromb Haemost 94:568577 Ewees MGE-D, Abdel-Bakky MS, Bayoumi AMA et al (2021) Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway Mohamed
It binds to adipose tissue and triggers breakdown of stored fat while blocking new fat storage (reesterification) in adipocytes [4]